Vaccine News and Research

Latest Vaccine News and Research

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Responding to delays in the nationwide distribution H1N1 flu vaccine, Department of Health officials today urged Pennsylvanians to continue to take steps to prevent the spread of illness.

30 Oct 2009

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

With just 36 hours notice from the Maricopa County Department of Public Health, Mollen Immunization Clinics administered over 14,000 vaccinations to high-risk groups throughout the county, one of the nation's largest with a population of four million residents.

30 Oct 2009

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

The Centers for Disease Control and Prevention (CDC) have classified all children, 6-months to 24-years, one of the high risk groups for contracting the H1N1 (swine) flu, and recommend this population receive the H1N1 vaccine for immunity against the disease.

30 Oct 2009

Scientists present new perspective on antigenic drift of flu viruses

Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. This shape-shifting, called antigenic drift, is why influenza vaccines-which are designed to elicit antibodies matched to each year's circulating virus strains-must be reformulated annually.

30 Oct 2009

Helper T cell's effect raises possibility of cellular therapy and vaccine development

A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson Cancer Center report in the early online edition of the journal Immunity.

30 Oct 2009

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

30 Oct 2009

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

30 Oct 2009

Leading gynecologist recommends flu shots for pregnant women

Randy A. Fink, MD says pregnant women ought to be shot – with a flu vaccination needle. “A flu shot offers double protection to both mother and baby,” says Dr. Fink, a Miami board certified specialist who was recently named one of “America's Top Obstetrician/Gynecologists” by the Consumer Research Council.

30 Oct 2009

Antioxidants may hold the key in preventing severe flu-related lung damage

As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. In an article appearing in the November 2009 print issue of the FASEB Journal (http://www.fasebj.org) they show that antioxidants-the same substances found in plant-based foods-might hold the key in preventing the flu virus from wreaking havoc on our lungs.

30 Oct 2009

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger.

30 Oct 2009

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

Highly publicized vaccine products not only boost the bottom lines of pharmaceutical companies, but also benefit insurance companies, doctors and retailers with their businesses, according to analysis of the recent flu vaccine season by life science market research publisher Kalorama Information.

30 Oct 2009

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.

30 Oct 2009

All Canadians need to be immunized against H1N1: CPHA

The Canadian Public Health Association (CPHA) announced today that it is encouraging Canadians to get the H1N1 vaccination. To help people make an informed choice, it is launching a new online portal of information.

30 Oct 2009

UCLA Kaiser Permanente Center expands to eliminate health disparities

The UCLA School of Public Health has received a $5.2 million gift from Kaiser Permanente to endow the UCLA Kaiser Permanente Center for Health Equity. The center, formerly known as the Center to Eliminate Health Disparities, is dedicated to improving the health of underserved populations through research, community collaboration and leadership development.

30 Oct 2009

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Dynavax Technologies Corporation today announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients.

30 Oct 2009

New online education course on H1N1 vaccination now available

mdBriefCase Inc., in collaboration with the Public Health Agency of Canada (PHAC), is pleased to provide a new online education course on H1N1 vaccination for health professionals.

30 Oct 2009

New campaign offers information and resources on seasonal and H1N1 flu prevention

Blue Cross Blue Shield of Arizona (BCBSAZ) says “Get the facts, not the flu,” in a new campaign that launches today at azblue.com/Flu. The flu campaign offers its members, employer groups and Arizona residents information and resources on seasonal and H1N1 flu prevention and immunization.

30 Oct 2009

Vaccine News and Research

Latest Vaccine News and Research

Health officials stress the need for continued prevention efforts in view of H1N1 vaccine delay

Mollen Immunization Clinics sets US record for administering 14,000 vaccinations in a single event

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Scientists present new perspective on antigenic drift of flu viruses

Helper T cell's effect raises possibility of cellular therapy and vaccine development

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Studies demonstrate that investigational cancer vaccines show encouraging immune response rates

Leading gynecologist recommends flu shots for pregnant women

Antioxidants may hold the key in preventing severe flu-related lung damage

Hard to Treat Diseases negotiating possible merger with EU based stem cell research company

Highly publicized vaccine products not only boost pharmaceutical companies, but also benefit others

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

All Canadians need to be immunized against H1N1: CPHA

UCLA Kaiser Permanente Center expands to eliminate health disparities

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

New online education course on H1N1 vaccination now available

New campaign offers information and resources on seasonal and H1N1 flu prevention

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

U.S. won't donate H1N1 vaccine to developing countries until 'at-risk' Americans receive vaccine

Obama administration hits reset button in wake of flu vaccine shortage

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in